Expression of endothelin-1 and endothelin-converting enzyme-1 mRNAs and proteins in failing human hearts

Journal of Cardiovascular Pharmacology

Volumn 31, Issue SUPPL. 1, 1998, Pages

  Fukuchi, Mitsumasa ^a   Giaid, Adel ^a  

^a MONTREAL GENERAL HOSPITAL   (Canada)

Author keywords

Endothelin 1; Endothelin converting enzyme 1; Heart failure; In situ hybridization; Macrophage

Indexed keywords

ASPARTIC PROTEINASE; ENDOTHELIN 1; ENDOTHELIN CONVERTING ENZYME; ENDOTHELIN-CONVERTING ENZYME 1; MESSENGER RNA; METALLOPROTEINASE; MUSCLE PROTEIN;

ARTICLE; BIOSYNTHESIS; CONGESTIVE HEART FAILURE; HEART MUSCLE; HUMAN; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; METABOLISM; PATHOLOGY;

ASPARTIC ENDOPEPTIDASES; ENDOTHELIN-1; HEART FAILURE, CONGESTIVE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; METALLOENDOPEPTIDASES; MUSCLE PROTEINS; MYOCARDIUM; RNA, MESSENGER;

EID: 0031643767     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199800001-00120     Document Type: Article

References (13)

1. Schomisch MC, Reynolds EE, Stewart RW, Bond M. Endothelin is a positive inotropic agent in human and rat heart in vitro. Biochem Biophys Res Commun 1989;159:14-8.
2. Stawski G, Olsen UB, Grande P. Cytotoxic effect of endothelin-1 during 'simulated' ischemia in cultured rat myocytes. Eur J Pharmacol 1991;201:123-4.
3. Shubeita HE, McDonough PM, Harris AN, et al. Endothelin induction of inositol phospholipid hydrolysis, sarcomere assembly, and cardiac gene expression in ventricular myocytes. J Biol Chem 1990;265:20555-62.
4. Guarda E, Katwa LC, Myers PR, Tyagi SC, Weber KT. Effects of endothelins on collagen turnover in cardiac fibroblasts. Cardiovasc Res 1993;27:2130-4.
5. Colucci WS. Myocardial endothelin; does it play a role in myocardial failure? Circulation 1996;93:1069-72.
6. Hiroe M, Hirata Y, Fujita N, et al. Plasma endothelin-1 levels in idiopathic dilated cardiomyopathy. Am J Cardiol 1991;68:1114-5.
7. McMurray JJ, Ray SG, Abdullah I, Dargie HJ, Morton JJ. Plasma endothelin in chronic heart failure. Circulation 1992;85:1374-9.
8. Wei C-M, Lerman A, Rodeheffer RJ, et al. Endothelin in human congestive heart failure. Circulation 1994;89:1580-6.
9. Sakai S, Miyauchi T, Kobayashi M, Yamaguchi I, Goto K, Sugishita Y. Inhibition of myocardial endothelin pathway improves long-term survival in heart failure. Nature 1996;384:353-5.
10. Giaid A, Yanagisawa M, Langleben D, et al. Expression of endothelin-1 in the lungs of patients with pulmonary hypertension. N Engl J Med 1993;328:1732-9.
11. Hexum TD, Hoeger C, Rivier JE, Baird A, Brown MR. Characterization of endothelin secretion by vascular endothelial cells. Biochem Biophys Res Commun 1990;167:294-300.
12. Fishbein MC, Maclean D, Maroko PR. The histopathologic evolution of myocardial infarction. Chest 1978;73:843-9.
13. Melillo G, Lima JAC, Judd RM, Goldschmidt-Clermont PJ, Silverman HS. Intrinsic myocyte dysfunction and tyrosine kinase pathway activation underlie the impaired wall thickening of adjacent regions during postinfarct left ventricular remodeling. Circulation 1996;93:1447-58.